Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Why Chipotle Mexican Grill, Inc. (CMG) Stock Is a Sell At Multi-Year Lows

CMG stock has tumbled to multi-year lows, but Chipotle is still over-valued and it has a long ways to go before it hits bottom.

Sears Holdings Corp (SHLD) Stock Jumps on Q2 Beat, But Don’t Blink

Sears posted better-than-expected Q2 results today, and SHLD stock is getting a trading bid higher. But an investment in Sears is folly.

Advanced Micro Devices’ (AMD) Tailwinds Might Taper Off

Advanced Micro Devices' management has righted the ship, and AMD stock has made investors a mint. But the way forward is more difficult.

4 “Safe” Dividends That Are Anything But

Don’t take any stated yields for granted these days! The financial news has been flooded with dividend cuts lately, with Teva Pharmaceutical (TEVA) and Ma...

If You Still Own Seadrill Ltd (SDRL) Stock, Here’s Your One Possible Upside

SDRL stock holders may finally be put out of their misery on Thursday, following earnings. The question is how Seadrill pulls its own plug.

Why Abercrombie & Fitch Co. (ANF) Stock Is STILL Far From Glamorous

Abercrombie & Fitch (ANF) has very little going for it right now: a failing flagship brand, pile of debt and a lack of future direction.

Earnings Dump Lowe’s Companies, Inc. (LOW) Stock Back to Second Place

Lowe's tanked to the tune of 5% early on Wednesday, as LOW stock proved its overhaul effort wasn't getting reliable traction yet.

Has Nokia Oyj (ADR) (NOK) Stock Finally Run Out of Steam?

Nokia stock has rebounded sharply in 2017. But growth and valuation concerns mean the run in NOK stock likely will stay stalled out.

Plug Power Inc (PLUG) Stock May Not Be a Smart Buy Yet

Plug Power's profit problem is not unique to the company, but it does make it hard to be excited for PLUG stock's new deals.

American Eagle Outfitters (AEO) Stock Is Quickly Losing Relevance

AEO stock will likely remain an underperformer as the American Eagle brand is indistinguishable from the noise of the fashion industry.

3 Stocks on the Brink of Collapse

Below the surface, a growing cohort of individual issues are rolling over, placing several stocks at risk. Here are the three that standout.

6 Crumbling Tech Stocks That Will Bury You Alive

The markets are rethinking this whole "Trump thing," and these already-volatile tech stocks could drop if stirred.

Bank of America Corp (BAC) Stock Is at Risk to Secular Technology Trends

Bank of America (BAC) is in trouble because lower interest rates are here to stay. Here's why investors should avoid BAC stock.

Foot Locker, Inc. (FL) Stock’s Pain Shows the Mall Is Dead

The death of shopping malls and the fall in stores like Foot Locker could portend bad days ahead for the economy -- and for FL stock right now.

Could the “New” Rite Aid Corporation (RAD) Go Broke?

The deal to sell 2,186 stores gives Rite Aid (RAD) breathing room, but that doesn't mean RAD stock is worth buying.

3 Reasons Ford Motor Company (F) Stock Will Remain In Neutral

F stock has gone nowhere. And unfortunately, it looks like there is not much to get Ford back on track. Here's what you need to know.

Chesapeake Energy Corporation (CHK) Stock Is Sliding Into Irrelevance

Chesapeake is trying to stay afloat with conservative accounting and good field operations, but it looks like a losing battle on the CHK stock balance sheet.

Blue Apron Holdings Inc (APRN) Stock Will Poison Bottom-Fishers

Jana Partners' recently revealed Blue Apron stake is far from a meaningful bullet point for the bulls. APRN stock still looks like garbage.

The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak

VRX stock has rebounded off single-digit levels earlier this year, but the bull case for Valeant Pharmaceuticals remains flimsy.